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Objectives: Searching for the presence of the mcr-1 gene in colistin resistant Enterobacteriaceae in
countries of the Arabian Peninsula.
Methods: Seventy-ﬁve independent, colistin resistant Enterobacteriaceae strains isolated from clinical
cases in Bahrain, Kuwait, Oman, Saudi Arabia and the United Arab Emirates were tested by PCR for the
mcr-1 gene. mcr-1 positive strains were genotyped, and their antibiotic susceptibility was established.
The mcr-1 containing plasmids were mobilized into Escherichia coli K-12 and their sequence was
determined.
Results: Four E. coli isolates (two from Bahrain, one from Saudi Arabia and one from the United Arab
Emirates) were identiﬁed carrying the mcr-1 gene on conjugative plasmids. They belonged to global
multidrug resistant E. coli clones, i.e. ST648, ST224, ST68 and ST131, respectively. One strain carried the
blaNDM-1 carbapenemase gene. Three strains carried mcr-1 on IncI2 type plasmids, one of them also
harboring a blaCTX-M-64 gene. In the fourth strain mcr-1 was located on a 240 kb IncHI2 plasmid co-
harboring 13 other resistance genes.
Conclusions: This is the ﬁrst report on the presence of the plasmid-coded mcr-1 gene in a variety of multi-
resistant clinical isolates from the Arabian Peninsula indicating that several commonly used antibiotics
can potentially facilitate the spread of mcr-1 carrying strains, or directly, mcr-1 containing plasmids.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The recent emergence and spread of carbapenem resistant
Enterobacteriaceae (CRE), Pseudomonas and Acinetobacter strains
has led to the re-introduction of colistin, i.e. a drug once considered
to be inconvenient and too toxic for routine parenteral use, into
daily clinical application.1 As for these pathogens colistin often
represents the last resort of treatment options, resistance to it
commonly leads to more severe complications and increased
mortality.2 Deletions, insertions or mutations in several chromo-
somal genes affecting the composition of the cell wall, thus* Corresponding author. Department of Medical Microbiology and Immunology
College of Medicine and Health Sciences UAE University Al Ain, PO Box 17666.
Tel.: +971 3 7137 480; fax: +971 3 7671 966.
E-mail address: tpal@uaeu.ac.ae (T. Pal).
http://dx.doi.org/10.1016/j.ijid.2016.07.007
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).preventing the efﬁcient binding of the drug, can lead to different
levels of decreased colistin susceptibility.3 The recent discovery of
Liu et al. describing a mobile colistin resistance gene (mcr-1)
located on a transferable plasmid has implied that colistin
resistance can also spread efﬁciently from strain to strain.4 Indeed,
mcr-1 emerged in a remarkable variety of strains recovered from
healthy carriers, food and environmental sources and clinical
isolates as well (reviewed in 5). Most of the mcr-1 positive isolates
carried different resistance genes, including carbapenemase genes,
namely blaNDM-9,
6 blaNDM-5,
7 blaVIM-1,
8 blaOXA-48-type,
9 and blaKPC-
2.
10 Importantly, in some cases other resistance genes were also co-
located on the mcr-1 carrying plasmids.8,11–14
Although mcr-1 expressing strains have been found in Asia,
Europe, North America and Africa,5 so far they have not been
reported from countries of the Arabian Peninsula. From these
countries nation-wide, surveillance-based data on antibioticciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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A´. Sonnevend et al. / International Journal of Infectious Diseases 50 (2016) 85–9086resistance, including the rate of carbapenem or colistin resistance,
is not available.15 In a recent, limited scale study, the rate of colistin
resistance among CRE strains collected in four countries of the
region was found to be 4.1%.16 Here we present data showing that
mcr-1 positive strains, represented by multi- drug resistant (MDR),
high risk clones, such as ST131, or by ones harbouringblaNDM-1
carbapenemase gene, are indeed present in countries of the region,
some carrying an mcr-1 plasmid also containing a large cluster of
resistance genes.
2. Materials and methods
2.1. Strains
Seventy-ﬁve colistin resistant (MIC >2 mg/L) Klebsiella pneu-
moniae and Escherichia coli strains were included in the study. The
strains were partly from our collection of CRE continuously
submitted to our laboratory for molecular typing, or had been sent
by different laboratories as colistin resistant isolates for the sake of
the current study, irrespective of their carbapenem susceptibility.
All strains were isolated from samples collected by clinical
indications and strains were submitted to us coded, without any
patient-identiﬁers. Eight of the 75 colistin resistant isolates were
part of a collection published earlier.16
2.2. Antibiotic susceptibility assay
Susceptibilities to most antibiotics were tested by microdilu-
tion and were interpreted by CLSI standards.17 Trimethoprim-
sulfamethoxazole sensitivity was assayed on VITEK-2 (BioMe´r-
ieux), while colistin sensitivity was tested by agar dilution and
interpreted by the EUCAST criteria.18 The minimum inhibitory
concentration (MIC) of chlorhexidine, benzalkonium and irgasan
was also established by agar dilution. Strains were considered
carbapenem non-susceptible if any of the three carbapenems
tested (i.e. imipenem, meropenem or ertapenem) exhibited an MIC
above their respective clinical breakpoints.
2.3. PCR for antibiotic resistance genes and virulence factors
The presence of the mcr-1 gene,4 and that of other resistance
genes (blaTEM, blaCTX-M, blaSHV, blaPER, blaAmpC, blaNDM, blaOXA-48-like,
blaKPC, blaVIM, blaIMP, armA, rmtA, rmtB, rmtC, rmtD, rmtE, rmtF, qnrS,
qepA, aac6-1b-cr, emrE, qacDE, qacF, qacE, mdfA, ydgE, ydgF, sugE(c),
sugE(p), cepA) was established as described.19,20 Speciﬁc alleles of
beta-lactamase genes were determined by direct sequencing of the
respective amplicons on a 3130X genetic analyzer (Applied
Biosystems). The presence of the virulence factor genes (cdt, hlyA,
papC, papA, papEF, ﬁmH, PAI, fyuA, bmaE, sfa/foc DE, iutA, traT, focG,
cvaC, gafD, sfaS, cnf1, afa/dra, nfaE, rfc, ibe A, iha, upaH, upaB, Kps
MTII, K5, K1, Kps MTIII, sat, ireA, iroN, usp, csgA, crl, bcsA) was tested
as described.21,22
2.4. Strain typing
Strains carrying mcr-1 were subjected to macrorestriction
analysis with XbaI (NE Biolabs, USA) digestion combined with
pulsed ﬁeld gel electrophoresis.16 Strains were also subjected to
multilocus sequence typing.23
2.5. Plasmid work
Plasmids were detected and sized by the alkaline lysis method
using episomes in E. coli 39R861 and E. coli V517 as molecular mass
controls.24 The mcr-1-containing plasmids were conjugally trans-
ferred into E. coli J53RAZ or, if unsuccessful as a single plasmid, by
A´. Sonnevend et al. / International Journal of Infectious Diseases 50 (2016) 85–90 87transformation into DH5a, as previously described25 using
selective plates containing 2 mg/L colistin. For transformation
and for sequencing purposes plasmids were puriﬁed using the
Plasmid Maxi Prep kit (Qiagen, Germany). Plasmid incompatibility
types were determined by PCR-based replicon typing (PBRT),26 and
by analysing the complete sequences of the plasmids. mcr-1
containing plasmids were submitted for commercial complete
sequencing performed by the CCIB DNA Core Facility at Massa-
chusetts General Hospital (Cambridge, MA). If the assembly could
not unambiguously determine the entire plasmid sequence, PCR
mapping and direct sequencing of the products was used for gap
closure. Antibiotic resistance genes on the assembled plasmid
sequences were identiﬁed by ResFinder 2.1.27 Sequences were
annotated using Sequin (http://www.ncbi.nlm.nih.gov/Sequin)
and submitted to GenBank.
3. Results
Seventy-ﬁve independent, colistin resistant Klebsiella pneumo-
niae and Escherichia coli strains collected in the Kingdom of
Bahrain, Kingdom of Saudi Arabia (KSA), Kuwait, Oman and in the
United Arab Emirates (UAE) were studied. The species, carbape-
nem susceptibility, carbapenemases produced and the countries of
origin of the strains are shown in Suppl. Table 1. Four E. coli strains
carrying the mcr-1 gene, two from Bahrain, one from Saudi Arabia
and one from the UAE were detected in this collection,
respectively. Two E. coli were isolated from blood in 2012 and
in 2013, a urine and a wound isolate were recovered in 2015
(Table 1.). Besides colistin, all four strains were uniformly resistant
to 3rd generation cephalosporins, tetracycline, trimetoprime/
sulfamethoxasole and gentamicin, and variably resistant to
amikacin, carbapenems, chloramphenicol and ciproﬂoxacin
(Table 2.).
Genotyping results (Table 1.) showed that the isolates were
clonally unrelated and belonged to different globally distributed
sequence types (STs), including ST131 (strain ABC149), associated
with the MDR phenotype. All isolates carried various types of ESBLTable 2
Antibiotic susceptibility of the mcr-1 donor and recipient strains
Antibioticsa Strains
BA76 J53RAZ
(pBA76-MCR-1)
BA77 J53RAZ
(pBA77-MCR-1)
S
Wb TCc W TC W
MIC
(mg/L)
COL 16 4 16 4 1
AMP >256 >256 >256 4 >
CAZ 128 8 16 <0.25 >
CTX >128 128 >128 <0.25 1
AZT >128 16 64 <0.25 <
ETP 1 <0.125 <0.125 <0.125 >
MEM 2 0.5 1 0.5 >
IMP <0.25 <0.25 <0.25 <0.25 1
CIP >64 <0.125 16 <0.125 0
AMK >256 <0.5 4 <0.5 >
GEN >256 <0.5 64 <0.5 >
KAN >256 1 >256 1 >
STR 64 1 256 1 >
TMP-SMX >320 <20 >320 <20 >
CHL 256 4 32 4 2
TET 128 <0.5 64 <0.5 2
ERY >256 64 64 64 2
BAC 128 64 128 64 1
CHX 2 2 2 2 2
IRG 0.25 <0.125 0.25 <0.125 0
a Antibiotics: COL – colistin, AMP – ampicillin, CAZ – ceftazidime, CTX – cefotaxime
ciproﬂoxacin, AMK – amikacin, GEN – gentamicin, KAN – kanamycin, STR – streptomy
tetracycline, ERY – erythromycin, BAC – benzalkonium, CHX – chlorhexidine, IRG - irg
bW – Wild type, cTC – Transconjugant, dTF – Transformant, eR – Recipientor carbapenemase genes. (Table 1). Isolate SA26 carried the blaNDM-
1 gene on a 95 kb non-typable plasmid, and expressed high level of
carbapenem resistance (Table 2.). Strain BA76 was intermediately
susceptible to some of the carbapenems (Table 2.) while not
carrying any of the carbapenemase genes tested. In this case no
further attempts were made to investigate the basis of the
decreased carbapenem susceptibility. One of the Bahraini and the
Saudi strain also carried 16S methylase genes, rmtB (BA76) or rmtC
(SA26), respectively.
Although all strains carried genes associated with disinfectant
resistance20 (Table 1.), no increase in MIC to the disinfectants
tested was detected compared to E. coli K12 laboratory strains
(Table 2).
All plasmids carrying the mcr-1 gene were transferred into E.
coli J53RAZ by conjugation. In case of ABC149, however, these
attempts have always resulted in transconjugants containing
multiple plasmids, suggesting that pABC149-mcr-1 is not self-
conjugative, but can be mobilized in trans by other conjugative
plasmid present in the same donor cell. Therefore, pABC149-mcr-1
was transferred by transformation into E. coli DH5a.
In three of the four strains, BA76, BA77 and ABC149,
respectively, the mcr-1 gene was located on approximately
60 kb size IncI2 plasmids, which in case of pBA76-mcr-1 also
harboured an ISEcp1-driven blaCTX-M-64 inserted independently of
mcr-1 at position 8357 of the plasmid scaffold (GenBank Acc. No.
KX013540). The backbones of all three plasmids, i.e. pBA76-mcr-1,
pBA77-mcr-1 (GenBank Acc. No. KX013539) and pABC149-mcr-1
(GenBank Acc. No. KX013538), respectively were highly similar to
that of the mcr-1 plasmid ﬁrst described (pHNSHP45),4 with some
variations in the shufﬂon region of the conjugative apparatus. The
genetic surroundings of the mcr-1 gene in the four plasmids,
together with examples available in GenBank, are shown in
Figure 1A. Upstream structures identical to those seen in pABC149-
mcr-1, pBA76-mcr-1 and pBA77-mcr-1 have been observed
earlier.28
The downstream region in all three IncI2 MCR-plasmids was
identical to that in the originally described pHNSHP45.4A26 J53RAZ
(pSA26-MCR-1)
ABC149 DH5a
(pABC149-MCR-1)
J53RAZ DH5a
 TC W TFd Re R
6 4 16 8 0.25 0.25
256 >256 >256 4 4 2
128 <0.25 128 <0.25 <0.25 <0.25
28 <0.25 >128 <0.25 <0.25 <0.25
0.25 <0.25 128 <0.25 <0.25 <0.25
64 <0.125 0.25 <0.125 <0.125 <0.125
128 0.5 1 0.5 0.5 <0.25
6 <0.25 <0.25 <0.25 <0.25 <0.25
.25 0.25 >64 <0.125 <0.125 <0.125
256 2 8 2 1 2
256 1 128 1 <0.5 <0.5
256 >256 128 2 0.5 2
256 32 128 4 2 4
320 >320 >320 <20 <20 <20
56 64 8 2 8 2
56 32 256 <0.5 <0.5 <0.5
56 64 >256 4 32 4
28 64 128 8 128 8
 2 2 0.5 2 0.5
.25 <0.125 0.25 <0.125 0.25 <0.125
, AZT – aztreonam, ETP – ertapenem, MEM – meropenem, IMP – imipenem, CIP –
cin, TMP-SMX – trimethoprim-sulphamethoxazole, CHL – chloramphenicol, TET –
asan
pSA26-mcr-1 (KU74338 4)
pHK0653 (KT3343 35.1)
pHXY0908 (KM877269 .1)
pHNSHP45-2 (KU3413 81)
tnp A mcr-1
ISApI1
tnp A
ISApI1
ΔHP
1pSA26-mcr-1
tnp A mcr-1
ISApI1
KU34138 1
KP3471 27
pABC149-mcr-1
mcr-1
3’ end of  IS ApI1
LNCZ0 1000 024
LFCC01000 022
LMBK0100030 8
JWKC0100 018 6
mcr-1
pBA76-mcr-1
pBA77-mcr-1
JUJZ010000 81
JWKF01000 084
JWKG0 1000 081
mcr-1LKJJ010 000 31
KU74338 3
mcr-1LKJD01 000 010
HP1
HP1
HP1
HP1
HP1
nikB
HP2
kinase
A
B
Figure 1. Comparison of the ﬂanking regions of the mcr-1 gene in different plasmids (A) and the antibiotic resistance gene cluster in pSA26-mcr-1 (B) to that in other plasmids.
A. Plasmids of the current study are printed bold, for other plasmids the respective GenBank numbers are provided. HP – hypothetical protein
B. Genes coding resistance to the different antibiotic classes are color-coded.
A´. Sonnevend et al. / International Journal of Infectious Diseases 50 (2016) 85–9088A completely different plasmid was identiﬁed in SA26. pSA26-
mcr-1 was a 240367 bp, IncHI2 type plasmid (GenBank Acc. No
KU743384). It exhibited extensive similarity to the backbone of the
mcr-1 negative, multidrug resistant plasmids pHK0653 (GenBank
Acc. No. KT334335) and pHXY0908 (GenBank Acc. No. KM877269)
carried by Salmonella Typhimurium strains isolated from human
and poultry samples in China, and to the more recently identiﬁed
second mcr-1 plasmid from the SHP45 pig isolate, pHNSHP45-2
(GenBank Acc. No. KU341381).29 However, in pSA26-mcr-1 a
resistance island located between positions 76369 and 113971 was
substantially different from the ones seen in these plasmids,
respectively (Figure 1B). pSA26-mcr-1 contained 13 differentresistance genes conferring aminoglycoside, beta-lactam, phenicol,
tetracycline, sulfonamide, trimethoprim and macrolide resistance.
The mcr-1 gene was not part of this resistance island, but was
identiﬁed in a different region, located between positions
160238 and 161863, ﬂanked both upstream and downstream by
a complete ISApal1 (Figure 1A).
4. Discussion
mcr-1-mediated colistin resistance, commonly found in carba-
penem susceptible strains, have been described in CRE, as well.6–10
While the former group can be instrumental in spreading colistin
A´. Sonnevend et al. / International Journal of Infectious Diseases 50 (2016) 85–90 89resistance, in case of a latter one it also seriously restricts
therapeutic options. Our current study conﬁrms the presence of
this resistance mechanism both in carbapenem susceptible and
non-susceptible Enterobacteriaceae in countries of the Arabian
Peninsula.
Three of the four mcr-1 plasmids identiﬁed exhibited consider-
able similarities to the approximately 60 kb IncI2 plasmids
described earlier.4 Although isolates producing mcr-1 and ESBL
enzymes are widespread, and even plasmids co-harboring ESBL
genes and mcr-1 have been described earlier,5 to the best of our
knowledge pBA76-mcr-1 is the ﬁrst IncI2 type plasmid found to
carry blaCTX-M-64 and mcr-1 simultaneously, which indicates that
this type of plasmids could also be co-selected by commonly used
beta-lactam antibiotics.
To the best of our knowledge, pSA26-mcr-1 is the ﬁrst
completely sequenced IncHI2 plasmid carrying mcr-1 and also
resistance genes to several other classes of antibiotics, from a
human E. coli isolate. Actually, MDR plasmids with this backbone
structure have been reported from different parts of the world from
animals and they increasingly seem to be important carriers of mcr-
1. Such IncHI2 group mcr-1 plasmid was ﬁrst identiﬁed30 by probing
the contigs in GenBank in a S. Typhimurium strain isolated in
2011 in Portugal from food sample (NZ_LFCC01000022). Subse-
quently, from Belgium, an E. coli strain containing plasmid pKH-
475-3-BE isolated from animal stool was reported. While consider-
ably smaller (approximately 80 kb) than the original S. Typhimur-
ium plasmids pHK0653 and pHXY0908, pKH-475-3-BE also showed
extensive homology to their backbones and carried a cluster of at
least 7 resistance genes beyond mcr-1.13 It should be noted that
further large plasmids, conferring resistance to multiple antibiotics
isolated from animal sources in Vietnam12 and in France, the latter
having the same IncHI2 type, have also been described.11 Further
mcr-1-containing IncHI2 plasmids, without characterizing other
antibiotic resistance genes located on it, have been reported from
various sources in Germany.10 Although no details of its sequence
was available, the mcr-1 gene in the IncHI2 plasmid from a human
isolate in that study was ﬂanked by ISApl1 transposase genes,10 just
as in plasmid pSA26-mcr-1 in this study (Figure 1A).
Although, pSA26-mcr-1 has a nearly identical backbone and
size to the pig E. coli SHP45 IncHI2 plasmid, pHNSHP45-2, it
contains a considerably different array of 13 resistance genes
(Figure 1B). The fact that pSA26-mcr-1, a multidrug resistant mcr-
1-containing plasmid, was detected in a human isolate indicates
that these plasmids, earlier reported in animal isolates, only10–
12,29,30 did spread into human pathogens, as well. As beyond
colistin, pSA26-mcr-1 also confers resistance to several antibiotics,
some of them broadly administered even to non-hospitalized
patients, treatment with these drugs could easily promote the
inter-strain, even inter-species spread of colistin resistance in the
community, as well.
While our data clearly showed the presence of mcr-1 mediated
colistin resistance in three countries of the Arabian Peninsula, due
to the limitations of compiling the pool of strains for the current
study one cannot draw any conclusion regarding the frequency of
mcr-1 in the different countries.
Nevertheless, the fact that 5.3% of the colistin resistant strains
tested carried the mcr-1 gene indicates that the presence of such
isolates in the region should be anticipated. The detection of mcr-1
in globally spreading MDR clones of E. coli in this region is of grave
concern.
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